Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine.
The pharmacokinetics and metabolism of quinidine were investigated in extensive and poor metabolisers of sparteine. No differences in plasma clearance, terminal half life, volume of distribution or cumulative urinary excretion of quinidine, 3-hydroxyquinidine and quinidine-N-oxide were observed between phenotypes. Thus, it is unlikely that quinidine metabolism is controlled by the sparteine/debrisoquine gene locus.
D000328:Adult; D005260:Female; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008297:Male; D011802:Quinidine / Q000378:metabolism*; D013034:Sparteine / Q000378:metabolism*
D013034:Sparteine; D011802:Quinidine